SEMA7A and metabolic dysfunction-associated steatotic liver disease: More recent hepatobiliary focussed publications identified mutations in Sema7a causing a gain of function, progressing disease; non-alcoholic fatty liver disease (NAFLD) and intrahepatic cholestasis [54, 57].